UBS Group »

Immunitybio shares owned by UBS Group

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.0M 926k 5.37
2023-12-31 $214k 43k 5.02
2023-09-30 $67k 40k 1.69
2023-06-30 $110k 40k 2.78
2023-03-31 $208k 114k 1.82
2022-12-31 $1.9M 369k 5.07
2022-09-30 $575k 116k 4.96
2022-06-30 $187k 50k 3.72
2022-03-31 $959k 173k 5.54
2021-12-31 $2.2M 355k 6.11
2021-09-30 $2.7M 279k 9.72
2021-06-30 $386k 27k 14.22
2021-03-31 $1.3M 56k 23.74